Publicaciones (60) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Anti-retinal Antibodies in Sarcoidosis

    Ocular Immunology and Inflammation, Vol. 32, Núm. 2, pp. 141-147

  2. Aprendizaje-Servicio en el entorno rural de León

    Innovación docente en la Universidad de León (Servicio de Publicaciones), pp. 165-172

  3. Correction to: Protective Effect of Protocatechuic Acid on TNBS-Induced Colitis in Mice Is Associated with Modulation of the SphK/S1P Signaling Pathway (Nutrients, (2017), 9, 3, (288), 10.3390/nu9030288)

    Nutrients

  4. Correction to: Role of Toll-like receptor 2 and 4 signaling pathways on the inflammatory response to resistance training in elderly subjects (AGE, (2014), 36, 6, (9734), 10.1007/s11357-014-9734-0)

    GeroScience

  5. Corrigendum: Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells (Journal of Cellular Physiology, 10.1002/jcp.26855)

    Journal of Cellular Physiology

  6. Efficacy and safety of regorafenib as a first-line agent alone or in combination with an immune checkpoint inhibitor for advanced hepatocellular carcinoma: a retrospective cohort study

    Journal of Gastrointestinal Oncology, Vol. 15, Núm. 3, pp. 1072-1081

  7. Impact of BMI and Cardiorespiratory Fitness on Oxidative Stress in Plasma and Circulating Exosomes Following Acute Exercise

    Biology, Vol. 13, Núm. 8

  8. Prevalence of sarcopenic obesity according to different diagnostic methods and cut-off points in candidates for bariatric surgery

    Clinical Nutrition, Vol. 43, Núm. 5, pp. 1087-1093

  9. Retraction: “Inhibition of the SphK1/S1P Signaling Pathway by Melatonin in Mice with Liver Fibrosis and Human Hepatic Stellate Cells,” (BioFactors, (2016), 43, 2, (272–82), 10.1002/biof.1342)

    BioFactors

  10. Retraction:“Inhibition of the SphK1/S1P Signaling Pathway by Melatonin in Mice with Liver Fibrosis and Human Hepatic Stellate Cells,” (BioFactors, (2016), 43, 2, (272–82), 10.1002/biof.1342)

    BioFactors

  11. Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345

  12. Strategies to enhance the response of liver cancer to pharmacological treatments

    American journal of physiology. Cell physiology, Vol. 327, Núm. 1, pp. C11-C33

2023

  1. Correction to: Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (Cancers, (2019), 11, 12, (1984), 10.3390/cancers11121984)

    Cancers

  2. Erratum: A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells (British Journal of Nutrition (2008) 100: 5 (968-976) DOI: 10.1017/S0007114508966083)

    British Journal of Nutrition

  3. Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation

    Acta Pharmacologica Sinica, Vol. 44, Núm. 5, pp. 1066-1082

  4. Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity

    Cells, Vol. 12, Núm. 8

  5. Influence of 12-Week Concurrent Training on Exosome Cargo and Its Relationship with Cardiometabolic Health Parameters in Men with Obesity

    Nutrients, Vol. 15, Núm. 13

  6. Neuropilins as potential biomarkers in hepatocel-lular carcinoma: a systematic review of basic and clinical implications

    Clinical and Molecular Hepatology, Vol. 29, Núm. 2, pp. 293-319

  7. Potencial valor pronóstico y diagnóstico de la neuropilina-1 en el carcinoma hepatocelular: relación con la pérdida de sensibilidad al tratamiento con lenvatinib

    Universidad de León

  8. Relationship Between Surface Temperature, Body Composition and Anthropometric Indicators of Obesity and Overweight

    International Journal of Morphology, Vol. 41, Núm. 6, pp. 1824-1832